Validation of the graded prognostic assessment for lung cancer with brain metastases using molecular markers (lung-molGPA)

Efficacy of Second-line Tyrosine Kinase Inhibitors in the Treatment of Metastatic Advanced Non-small-cell Lung Cancer Harboring Exon 19 and 21 EGFR Mutations

(2017) Zhen Zheng et al.   Journal of Cancer

Estimating Survival in Patients With Lung Cancer and Brain Metastases

(2017) Paul W. Sperduto et al.   JAMA Oncology

Risk of brain metastases in patients with nonmetastatic lung cancer: Analysis of the Metropolitan Detroit Surveillance, Epidemiology, and End Results (SEER) data

(2016) Priscila H. Goncalves et al.   CANCER

Prognostic factors and long-term survival in surgically treated brain metastases from non-small cell lung cancer

(2016) Frederik Enders et al.   CLINICAL NEUROLOGY AND NEUROSURGERY

Predicted survival in patients with brain metastases from colorectal cancer: Is a current nomogram helpful?

(2016) Carsten Nieder et al.   CLINICAL NEUROLOGY AND NEUROSURGERY

Gamma Knife Radiosurgery in the management of single and multiple brain metastases

(2016) D. Greto et al.   CLINICAL NEUROLOGY AND NEUROSURGERY

Stereotactic fractionated radiotherapy of the resection cavity in patients with one to three brain metastases

(2016) Angelika Bilger et al.   CLINICAL NEUROLOGY AND NEUROSURGERY

The Effect of Gene Alterations and Tyrosine Kinase Inhibition on Survival and Cause of Death in Patients With Adenocarcinoma of the Lung and Brain Metastases

(2016) Paul W. Sperduto et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Pooled Analysis of CNS Response to Alectinib in Two Studies of Pretreated Patients With ALK-Positive Non–Small-Cell Lung Cancer

(2016) Shirish M. Gadgeel et al.   JOURNAL OF CLINICAL ONCOLOGY

Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial

(2016) Paula Mulvenna et al.   LANCET

Survival of patients with brain metastases from non-small cell lung cancer harboring EGFR mutations treated with epidermal growth factor receptor tyrosine kinase inhibitors

(2016) Jumpei Kashima et al.   MEDICAL ONCOLOGY

The effect of non-small cell lung cancer histology on survival as measured by the graded prognostic assessment in patients with brain metastases treated by hypofractionated stereotactic radiotherapy

(2016) Liang-Hua Ma et al.   Radiation Oncology

Hypo-fractionated stereotactic radiotherapy alone using volumetric modulated arc therapy for patients with single, large brain metastases unsuitable for surgical resection

(2016) Pierina Navarria et al.   Radiation Oncology

Stereotactic radiotherapy of the tumor bed compared to whole brain radiotherapy after surgery of single brain metastasis: Results from a randomized trial

(2016) Lucyna Kępka et al.   RADIOTHERAPY AND ONCOLOGY

Immunotherapy for Lung Cancer

(2016) Niels Reinmuth et al.   Oncology Research and Treatment

Prognostic indices in stereotactic radiotherapy of brain metastases of non-small cell lung cancer

(2015) David Kaul et al.   Radiation Oncology

Five-fraction stereotactic radiosurgery (SRS) for single inoperable high-risk non-small cell lung cancer (NSCLC) brain metastases

(2015) Jonathan W. Lischalk et al.   Radiation Oncology

EGFR tyrosine kinase inhibitors versus cranial radiation therapy for EGFR mutant non-small cell lung cancer with brain metastases: A systematic review and meta-analysis

(2015) Yu Yang Soon et al.   RADIOTHERAPY AND ONCOLOGY

Patient selection for whole brain radiotherapy (WBRT) in a large lung cancer cohort: Impact of a new Dutch guideline on brain metastases

(2014) Lizza E. L. Hendriks et al.   ACTA ONCOLOGICA

Prognostic Models Predicting Survival of Patients with Brain Metastases: Integration of Lactate Dehydrogenase, Albumin and Extracranial Organ Involvement

(2014) C. Nieder et al.   CLINICAL ONCOLOGY

Stereotactic radiosurgery (SRS) for brain metastases: a systematic review

(2014) Carsten Nieder et al.   Radiation Oncology

Patterns of distant brain recurrences after radiosurgery alone for newly diagnosed brain metastases: Implications for salvage therapy

(2014) Jaap D. Zindler et al.   RADIOTHERAPY AND ONCOLOGY

Radiotherapy versus best supportive care in patients with brain metastases and adverse prognostic factors

(2013) Carsten Nieder et al.   CLINICAL & EXPERIMENTAL METASTASIS

The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast cancer

(2013) Paul W. Sperduto et al.   JOURNAL OF NEURO-ONCOLOGY

Diagnosis-specific graded prognostic assessment score is valid in patients with brain metastases treated in routine clinical practice in two European countries

(2013) Carsten Nieder et al.   MEDICAL SCIENCE MONITOR

Non-small cell lung cancer histological subtype has prognostic impact in patients with brain metastases

(2012) Carsten Nieder et al.   MEDICAL ONCOLOGY

A nomogram for individualized estimation of survival among patients with brain metastasis

(2012) J. S. Barnholtz-Sloan et al.   NEURO-ONCOLOGY

Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases

(2011) Paul W. Sperduto et al.   JOURNAL OF CLINICAL ONCOLOGY

Presentation, patterns of care, and survival in patients with brain metastases

(2010) Carsten Nieder et al.   CANCER

Diagnosis-Specific Prognostic Factors, Indexes, and Treatment Outcomes for Patients With Newly Diagnosed Brain Metastases: A Multi-Institutional Analysis of 4,259 Patients

(2009) Paul W. Sperduto et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Prognostic Scores in Patients with Brain Metastases from Non-small Cell Lung Cancer

(2009) Carsten Nieder et al.   Journal of Thoracic Oncology